Advertisement

Shedding light on vasculitis in Egypt: a multicenter retrospective cohort study of characteristics, management, and outcome

  • Doaa Hassan Sayed AttiaEmail author
  • Rasha A. Abdel Noor
  • Shaimaa Salah
Original Article
  • 60 Downloads

Abstract

Objectives

The frequency of different vasculitides and their characteristics vary among different regions. The identification of geographic disparities of disease phenotypes helps the development of international criteria, allowing the classification of patients of different ethnicities. This study aimed to describe the frequency, characteristics, course, response to treatment, and outcome of the different adulthood vasculitides in Egypt.

Methods

This was a multicenter study in which the medical records of adult Egyptian patients diagnosed with vasculitis between 2002 and 2018 were retrospectively reviewed.

Results

The most frequent vasculitides in Egypt were Behçet’s disease (76%), hepatitis C virus vasculitis (13.9%), and granulomatosis with polyangiitis (3.9%). Most patients (73.8%) had a major event at the time of diagnosis. Generalized granulomatosis with polyangiitis was more common than the localized type (90% versus 10%, respectively). The aortic arch and its branches were the most common affected sites of Takayasu arteritis. Of vasculitides, Behçet’s disease and giant cell arteritis were associated with the greatest rates of relapse (62.7% and 33.3%, respectively). Delayed diagnosis and permanent organ damage were reported in 69.9% and 68.9% of patients, respectively. A low mortality rate was noted (1.3%).

Conclusions

The most common types of adulthood vasculitides in Egypt are Behçet’s disease, hepatitis C virus vasculitis, and granulomatosis with polyangiitis. Major organ involvement is frequent. Delayed diagnosis and permanent organ damage are common.

Keywords

Egypt Epidemiology Geography Vasculitides Vasculitis 

Notes

Acknowledgements

The authors would like to thank Prof Dr. Geilan Mahmoud Abd El-Moniem, Professor of Rheumatology and Clinical Immunology, Cairo University, for reviewing the work and providing valuable advice.

Compliance with ethical standards

Disclosures

None.

References

  1. 1.
    Jennette JC, Falk RJ, Bacon PA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1–11CrossRefGoogle Scholar
  2. 2.
    Kobayashi S, Fujimoto S (2013) Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol 17:611–614CrossRefGoogle Scholar
  3. 3.
    Watts RA (2005) Epidemiology of vasculitis in India-what is known? J Indian Rheumatol Assoc 13:8–15Google Scholar
  4. 4.
    Leonardo NM, McNeil J (2015) Behçet’s disease: is there geographical variation? a review far from the Silk Road. Int J Rheumatol 2015:945262.  https://doi.org/10.1155/2015/945262
  5. 5.
    Arend WP, Michel BA, Bloch DA (1990) American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefGoogle Scholar
  6. 6.
    Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ et al (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093CrossRefGoogle Scholar
  7. 7.
    Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr (1990) The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis. Arthritis Rheum 33(8):1101–1107CrossRefGoogle Scholar
  8. 8.
    Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100CrossRefGoogle Scholar
  9. 9.
    Calabrese LH, Michel BA, Bloch DA, Arend WP, Edworthy SM, Fauci AS, Fries JF, Hunder GG, Leavitt RY, Lie JT (1990) American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33:1108–1113CrossRefGoogle Scholar
  10. 10.
    International Team for the Revision of International Criteria for Behçet’s Disease (2008) Clinical manifestations of Behçet’s disease. The ITR-ICBD report. Clin Exp Rheumatol 26(Suppl 50):S1–S18Google Scholar
  11. 11.
    Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J et al (2002) Standardized nomenclature for glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61(8):718–722CrossRefGoogle Scholar
  12. 12.
    Boki KA, Dafni U, Karpouzas GA, Papasteriades C, Papasteriades C, Drosos AA et al (1997) Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. Br J Rheumatol 36(10):1059–1066CrossRefGoogle Scholar
  13. 13.
    Chaudhry IA, Shamsi FA, Elzaridi E, Arat YO, Bosley TM, Riley FC (2007) Epidemiology of giant-cell arteritis in an Arab population: a 22-year study. Br J Ophthalmol 91:715–718CrossRefGoogle Scholar
  14. 14.
    Khalifa M, Karmani M, Jaafoura NG, Kaabia N, Letaief AO, Bahri F; Study Group of GCA in Tunisia (2009) Epidemiological and clinical features of giant cell arteritis in Tunisia. Eur J Intern Med 20:208–212Google Scholar
  15. 15.
    Shahin AA, Zayed HS, Elrefai RM, Taher H, Elsaie A, Senara SH, Fathi HM, Omar G, Abd Elazeem MI (2018) The distribution and outcome of vasculitic syndromes among Egyptians: a multi-centre study including 630 patients. Egyptian Rheumatol 40(4):243–248CrossRefGoogle Scholar
  16. 16.
    Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2015) Behçet's syndrome: a critical digest of the 2014–2015 literature. Clin Exp Rheumatol 33:S3–S14Google Scholar
  17. 17.
    Mohammad A, Mandl T, Sturfelt G, Segelmark M (2013) Incidence, prevalence and clinical characteristics of Behçet’s disease in southern Sweden. Rheumatology (Oxford) 52(2):304–310CrossRefGoogle Scholar
  18. 18.
    Kitaichi N, Miyazaki A, Iwata D, Ohno S, Stanford MR, Chams H et al (2007) Ocular features of Behçet’s disease: an international collaborative study. Br J Ophthalmol 91(12):1579–1582CrossRefGoogle Scholar
  19. 19.
    Joshi VR, Mittal G (2006) Vasculitis—Indian perspective. J Assoc Physicians India 54(Suppl):12–14Google Scholar
  20. 20.
    Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M et al (2010) Behçet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis 13:367–373CrossRefGoogle Scholar
  21. 21.
    Bang D, Oh S, Lee KH, Lee ES, Lee S (2003) Influence of sex on patients with Behçet's disease in Kore. J Korean Med Sci 18(2):231–235CrossRefGoogle Scholar
  22. 22.
    Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B (2010) Behçet’s disease: from east to west. Clin Rheumatol 29(8):823–833CrossRefGoogle Scholar
  23. 23.
    Ames PRJ, Steuer A, Pap A, Denman AM (2001) Thrombosis in Behçet’s disease: a retrospective survey from a single UK centre. Rheumatology 40(6):652–655CrossRefGoogle Scholar
  24. 24.
    Joseph FG, Scolding NJ (2007) Neuro-Behçet’s disease in Caucasians: a study of 22 patients. Eur J Neurol 14(2):174–180CrossRefGoogle Scholar
  25. 25.
    Sansonno D, Dammacco F (2005) Hepatitis C virus, cryoglobulinemia, and vasculitis: immune complex relations. Lancet Infect Dis 5:227–236CrossRefGoogle Scholar
  26. 26.
    Mohammed RH, ElMakhzangy HI, Gamal A, Mekky F, El Kassas M, Mohammed N et al (2010) Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians. Clin Rheumatol 29(12):1373–1380CrossRefGoogle Scholar
  27. 27.
    Terrier B, Jehan F, Munteanu M, Geri G, Saadoun D, Sène D et al (2012) Low 25-hydroxyvitamin D serum levels correlate with the presence of extrahepatic manifestations in chronic hepatitis C virus infection. Rheumatology (Oxford) 51(11):2083–2090CrossRefGoogle Scholar
  28. 28.
    Johnson R, Gretch D, Yamabe H, Hart J, Bacchi CE, Hartwell P et al (1993) Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465–470CrossRefGoogle Scholar
  29. 29.
    Terrier B, Semoun O, Saadoun D, Font J (2011) Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis Rheum 63(6):1748–1757CrossRefGoogle Scholar
  30. 30.
    Gamarra AI, Coral P, Quintana G, Toro CE, Flores LF, Matteson EL et al (2010) History of primary vasculitis in Latin America. Med Sci Monit 16(3):RA58–RA72Google Scholar
  31. 31.
    Furuta S, Chaudhry AN, Hamano Y, Fujimoto S, Nagafuchi H, Makino H, Matsuo S, Ozaki S, Endo T, Muso E, Ito C, Kusano E, Yamagata M, Ikeda K, Kashiwakuma D, Iwamoto I, Westman K, Jayne D (2014) Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 41:325–333CrossRefGoogle Scholar
  32. 32.
    Handa R, Wali JP, Biswas A, Aggarwal P, Wig N (1997) Wegener’s granulomatosis- a clinicopathologic study. J Assoc Physicians India 45:536–539Google Scholar
  33. 33.
    Ishida Y, Katada A, Kishibe K, Imada M, Hayashi T, Nonaka S, Harabuchi Y (2004) Wegener’s granulomatosis with otolaryngological symptoms. Practica Oto-Rhino-Laryngol 97:997–1005CrossRefGoogle Scholar
  34. 34.
    Furuta S, Chaudhry AN, Arimura Y, Dobashi H, Fujimoto S, Homma S, Rasmussen N, Jayne DR (2017) Comparison of the phenotype and outcome of granulomatosis with polyangiitis between UK and Japanese cohorts. J Rheumatol 44:216–222CrossRefGoogle Scholar
  35. 35.
    Arulkumaran N, Periselneris N, Gaskin G, Strickland N, Ind PW, Pusey CD, Salama AD (2011) Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 50:2035–2043CrossRefGoogle Scholar
  36. 36.
    Oh JS, Lee CK, Kim YG, Nah SS, Moon HB, Yoo B (2009) Clinical features and outcomes of microscopic polyangiitis in Korea. J Korean Med Sci 24:269–274CrossRefGoogle Scholar
  37. 37.
    Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919–929CrossRefGoogle Scholar
  38. 38.
    Numano F (2002) The story of Takayasu arteritis. Rheumatology (Oxford) 41:103–106CrossRefGoogle Scholar
  39. 39.
    Numano F (1997) Differences in clinical presentation and outcome in different countries for Takayasu’s arteritis. Curr Opin Rheumatol 9:12–15CrossRefGoogle Scholar
  40. 40.
    Ogino H, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Matsumura Y, Ishibashi-Ueda H, Kobayashi J, Yagihara T, Kitamura S (2008) Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circ 118:2738–2747CrossRefGoogle Scholar
  41. 41.
    Hellmann DB (2017) Giant cell arteritis, polymyalgia rheumatica, and Takayasu’s arteritis. In: Firestein GS, Budd RC, Gabriel SE, Mcinnes LB, O'Dell JR et al (eds) Kelley & Firestein’s textbook of rheumatology, 10th edn. Elsevier, Philadelphia, pp 1520–1540CrossRefGoogle Scholar
  42. 42.
    Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337CrossRefGoogle Scholar
  43. 43.
    McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP (1989) Hepatitis B-associated polyarteritis nodosa in Alaskan eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology 9:97–101CrossRefGoogle Scholar
  44. 44.
    Handa R, Wali JP, Gupta SD, Dinda AK, Aggarwal P, Wig N, Biswas A (2001) Classic polyarteritis nodosa and microscopic polyangiitis-a clinicopathologic study. J Assoc Physicians India 49:314–319Google Scholar
  45. 45.
    Attia TH, Morsy SM, Hassan BA, Ali ASA (2018) Kawasaki disease among Egyptian children: a case series. Glob Cardiol Sci Pract 2017, 25.  https://doi.org/10.21542/gcsp.2017.25

Copyright information

© International League of Associations for Rheumatology (ILAR) 2019

Authors and Affiliations

  1. 1.Rheumatology and Rehabilitation Department, Faculty of MedicineCairo University HospitalsCairoEgypt
  2. 2.Internal Medicine and Rheumatology Department, Faculty of MedicineTanta UniversityTantaEgypt
  3. 3.Rheumatology and Rehabilitation Department, Faculty of MedicineAssiut UniversityAssiutEgypt

Personalised recommendations